Bio-Rad Laboratories Current Ratio 2012-2025 | BIO
Current and historical current ratio for Bio-Rad Laboratories (BIO) from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bio-Rad Laboratories current ratio for the three months ending September 30, 2025 was 5.44.
| Bio-Rad Laboratories Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $2.84B | $0.52B | 5.44 |
| 2025-06-30 | $2.81B | $0.55B | 5.12 |
| 2025-03-31 | $3.04B | $0.51B | 5.99 |
| 2024-12-31 | $3.03B | $0.47B | 6.48 |
| 2024-09-30 | $3.06B | $0.50B | 6.14 |
| 2024-06-30 | $3.06B | $0.49B | 6.28 |
| 2024-03-31 | $3.06B | $0.47B | 6.57 |
| 2023-12-31 | $3.05B | $0.52B | 5.83 |
| 2023-09-30 | $3.15B | $0.56B | 5.64 |
| 2023-06-30 | $3.14B | $0.58B | 5.39 |
| 2023-03-31 | $3.28B | $0.59B | 5.56 |
| 2022-12-31 | $3.16B | $0.57B | 5.55 |
| 2022-09-30 | $3.14B | $0.57B | 5.50 |
| 2022-06-30 | $3.25B | $0.61B | 5.30 |
| 2022-03-31 | $3.30B | $0.65B | 5.10 |
| 2021-12-31 | $1.99B | $0.68B | 2.92 |
| 2021-09-30 | $2.47B | $0.65B | 3.80 |
| 2021-06-30 | $2.29B | $0.59B | 3.90 |
| 2021-03-31 | $2.18B | $0.61B | 3.57 |
| 2020-12-31 | $2.14B | $0.63B | 3.39 |
| 2020-09-30 | $2.32B | $0.99B | 2.36 |
| 2020-06-30 | $2.13B | $0.93B | 2.30 |
| 2020-03-31 | $2.08B | $0.87B | 2.40 |
| 2019-12-31 | $2.18B | $0.91B | 2.41 |
| 2019-09-30 | $2.05B | $0.43B | 4.72 |
| 2019-06-30 | $2.09B | $0.45B | 4.68 |
| 2019-03-31 | $2.03B | $0.44B | 4.57 |
| 2018-12-31 | $2.02B | $0.45B | 4.49 |
| 2018-09-30 | $2.03B | $0.45B | 4.49 |
| 2018-06-30 | $1.99B | $0.44B | 4.50 |
| 2018-03-31 | $1.98B | $0.46B | 4.33 |
| 2017-12-31 | $1.98B | $0.50B | 3.93 |
| 2017-09-30 | $1.89B | $0.47B | 4.06 |
| 2017-06-30 | $1.83B | $0.46B | 4.01 |
| 2017-03-31 | $1.73B | $0.41B | 4.25 |
| 2016-12-31 | $1.85B | $0.47B | 3.91 |
| 2016-09-30 | $1.85B | $0.44B | 4.18 |
| 2016-06-30 | $1.81B | $0.41B | 4.40 |
| 2016-03-31 | $1.78B | $0.40B | 4.43 |
| 2015-12-31 | $1.78B | $0.44B | 4.03 |
| 2015-09-30 | $1.79B | $0.44B | 4.12 |
| 2015-06-30 | $1.74B | $0.40B | 4.31 |
| 2015-03-31 | $1.70B | $0.42B | 4.08 |
| 2014-12-31 | $1.72B | $0.45B | 3.84 |
| 2014-09-30 | $1.76B | $0.50B | 3.50 |
| 2014-06-30 | $1.77B | $0.48B | 3.68 |
| 2014-03-31 | $1.77B | $0.48B | 3.67 |
| 2013-12-31 | $1.76B | $0.49B | 3.61 |
| 2013-09-30 | $1.68B | $0.46B | 3.62 |
| 2013-06-30 | $1.90B | $0.43B | 4.41 |
| 2013-03-31 | $1.87B | $0.45B | 4.18 |
| 2012-12-31 | $1.94B | $0.47B | 4.10 |
| 2012-09-30 | $1.85B | $0.43B | 4.26 |
| 2012-06-30 | $1.81B | $0.42B | 4.34 |
| 2012-03-31 | $1.82B | $0.44B | 4.09 |
| 2011-12-31 | $1.80B | $0.46B | 3.92 |
| 2011-09-30 | $1.88B | $0.42B | 4.52 |
| 2011-06-30 | $1.89B | $0.44B | 4.27 |
| 2011-03-31 | $1.80B | $0.43B | 4.20 |
| 2010-12-31 | $1.98B | $0.67B | 2.96 |
| 2010-09-30 | $1.65B | $0.41B | 4.02 |
| 2010-06-30 | $1.56B | $0.39B | 3.99 |
| 2010-03-31 | $1.54B | $0.40B | 3.88 |
| 2009-12-31 | $1.56B | $0.42B | 3.72 |
| 2009-09-30 | $1.50B | $0.42B | 3.62 |
| 2009-06-30 | $1.40B | $0.38B | 3.64 |
| 2009-03-31 | $1.05B | $0.36B | 2.95 |
| 2008-12-31 | $1.09B | $0.42B | 2.62 |
| 2008-09-30 | $1.08B | $0.39B | 2.81 |
| 2008-06-30 | $1.12B | $0.41B | 2.74 |
| 2008-03-31 | $1.05B | $0.39B | 2.71 |
| 2007-12-31 | $1.03B | $0.41B | 2.48 |
| 2007-09-30 | $1.22B | $0.29B | 4.26 |
| 2007-06-30 | $1.17B | $0.28B | 4.14 |
| 2007-03-31 | $1.13B | $0.27B | 4.15 |
| 2006-12-31 | $1.13B | $0.32B | 3.54 |
| 2006-09-30 | $1.09B | $0.28B | 3.88 |
| 2006-06-30 | $1.06B | $0.28B | 3.77 |
| 2006-03-31 | $0.99B | $0.26B | 3.83 |
| 2005-12-31 | $1.01B | $0.32B | 3.16 |
| 2005-09-30 | $0.95B | $0.30B | 3.18 |
| 2005-06-30 | $0.92B | $0.29B | 3.15 |
| 2005-03-31 | $0.92B | $0.30B | 3.09 |
| 2004-12-31 | $0.91B | $0.32B | 2.88 |
| 2004-09-30 | $0.66B | $0.27B | 2.42 |
| 2004-06-30 | $0.66B | $0.21B | 3.13 |
| 2004-03-31 | $0.66B | $0.22B | 3.00 |
| 2003-12-31 | $0.66B | $0.24B | 2.74 |
| 2003-09-30 | $0.63B | $0.23B | 2.69 |
| 2003-06-30 | $0.49B | $0.22B | 2.26 |
| 2003-03-31 | $0.47B | $0.22B | 2.18 |
| 2002-12-31 | $0.47B | $0.21B | 2.23 |
| 2002-09-30 | $0.46B | $0.21B | 2.18 |
| 2002-06-30 | $0.44B | $0.20B | 2.18 |
| 2002-03-31 | $0.44B | $0.19B | 2.24 |
| 2001-12-31 | $0.43B | $0.20B | 2.16 |
| 2001-09-30 | $0.42B | $0.22B | 1.96 |
| 2001-06-30 | $0.40B | $0.20B | 1.97 |
| 2001-03-31 | $0.38B | $0.19B | 1.99 |
| 2000-12-31 | $0.37B | $0.19B | 1.95 |
| 2000-09-30 | $0.36B | $0.18B | 1.93 |
| 2000-06-30 | $0.38B | $0.19B | 2.01 |
| 2000-03-31 | $0.38B | $0.19B | 2.06 |
| 1999-12-31 | $0.38B | $0.20B | 1.87 |
| 1999-09-30 | $0.24B | $0.09B | 2.61 |
| 1999-06-30 | $0.24B | $0.09B | 2.76 |
| 1999-03-31 | $0.24B | $0.09B | 2.64 |
| 1998-12-31 | $0.24B | $0.10B | 2.42 |
| 1998-09-30 | $0.23B | $0.09B | 2.44 |
| 1998-06-30 | $0.24B | $0.10B | 2.51 |
| 1998-03-31 | $0.24B | $0.10B | 2.42 |
| 1997-12-31 | $0.23B | $0.10B | 2.26 |
| 1997-09-30 | $0.20B | $0.08B | 2.40 |
| 1997-06-30 | $0.20B | $0.08B | 2.54 |
| 1997-03-31 | $0.20B | $0.08B | 2.44 |
| 1996-12-31 | $0.20B | $0.08B | 2.51 |
| 1996-09-30 | $0.21B | $0.08B | 2.76 |
| 1996-06-30 | $0.21B | $0.08B | 2.53 |
| 1996-03-31 | $0.21B | $0.09B | 2.42 |
| 1995-12-31 | $0.20B | $0.09B | 2.24 |
| 1995-09-30 | $0.20B | $0.09B | 2.27 |
| 1995-06-30 | $0.20B | $0.10B | 2.03 |
| 1995-03-31 | $0.20B | $0.10B | 1.95 |
| 1994-12-31 | $0.18B | $0.09B | 1.98 |
| 1994-09-30 | $0.18B | $0.09B | 1.92 |
| 1994-06-30 | $0.18B | $0.09B | 1.92 |
| 1994-03-31 | $0.18B | $0.09B | 1.98 |
| 1993-12-31 | $0.17B | $0.09B | 1.94 |
| 1993-09-30 | $0.18B | $0.12B | 1.52 |
| 1993-06-30 | $0.19B | $0.13B | 1.49 |
| 1993-03-31 | $0.19B | $0.10B | 1.93 |
| 1992-12-31 | $0.18B | $0.10B | 1.84 |
| 1992-09-30 | $0.18B | $0.11B | 1.74 |
| 1992-06-30 | $0.21B | $0.13B | 1.63 |
| 1992-03-31 | $0.17B | $0.09B | 1.83 |
| 1991-12-31 | $0.17B | $0.09B | 1.81 |
| 1991-09-30 | $0.16B | $0.09B | 1.77 |
| 1991-06-30 | $0.15B | $0.09B | 1.67 |
| 1991-03-31 | $0.15B | $0.09B | 1.74 |
| 1990-12-31 | $0.15B | $0.09B | 1.74 |
| 1990-09-30 | $0.14B | $0.08B | 1.84 |
| 1990-06-30 | $0.14B | $0.08B | 1.73 |
| 1990-03-31 | $0.13B | $0.08B | 1.74 |
| 1989-12-31 | $0.12B | $0.07B | 1.67 |
| 1989-09-30 | $0.12B | $0.07B | 1.77 |
| 1989-06-30 | $0.12B | $0.06B | 1.92 |
| 1989-03-31 | $0.12B | $0.07B | 1.86 |
| 1988-12-31 | $0.10B | $0.05B | 1.91 |
| 1988-09-30 | $0.09B | $0.05B | 1.82 |
| 1988-06-30 | $0.09B | $0.05B | 1.76 |
| 1988-03-31 | $0.09B | $0.05B | 1.78 |
| 1987-12-31 | $0.09B | $0.05B | 1.88 |
| 1987-09-30 | $0.08B | $0.04B | 2.00 |
| 1987-06-30 | $0.08B | $0.04B | 1.88 |
| 1987-03-31 | $0.07B | $0.04B | 1.85 |
| 1986-12-31 | $0.06B | $0.03B | 1.93 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.922B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $197.518B | 22.06 |
| EssilorLuxottica (ESLOY) | France | $154.739B | 0.00 |
| Stryker (SYK) | United States | $139.087B | 26.68 |
| Medtronic (MDT) | Ireland | $129.586B | 17.95 |
| Boston Scientific (BSX) | United States | $108.915B | 24.09 |
| Medline (MDLN) | United States | $59.170B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.091B | 0.00 |
| ResMed (RMD) | United States | $37.821B | 25.25 |
| Agilent Technologies (A) | United States | $36.458B | 23.10 |
| GE HealthCare Technologies (GEHC) | United States | $36.095B | 17.29 |
| Koninklijke Philips (PHG) | Netherlands | $30.881B | 18.33 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 11.66 |
| Insulet (PODD) | United States | $17.647B | 54.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.998B | 0.00 |
| Baxter (BAX) | United States | $11.448B | 9.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.976B | 25.22 |
| Lantheus Holdings (LNTH) | United States | $4.461B | 13.59 |
| BillionToOne (BLLN) | United States | $3.924B | 0.00 |
| ICU Medical (ICUI) | United States | $3.647B | 23.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.122B | 14.73 |
| Haemonetics (HAE) | United States | $2.672B | 11.69 |
| Neogen (NEOG) | United States | $2.338B | 51.19 |
| Phibro Animal Health (PAHC) | United States | $2.088B | 18.40 |
| Perrigo (PRGO) | Ireland | $2.009B | 5.03 |
| LeMaitre Vascular (LMAT) | United States | $1.991B | 40.08 |
| QuidelOrtho (QDEL) | United States | $1.956B | 13.59 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.625B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Green Thumb Industries (GTBIF) | United States | $1.390B | 60.91 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.304B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.071B | 317.86 |
| InMode (INMD) | Israel | $0.902B | 9.89 |
| Tilray Brands (TLRY) | Canada | $0.888B | 0.00 |
| Valneva SE (VALN) | France | $0.834B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.763B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.570B | 13.61 |
| Brainsway (BWAY) | Israel | $0.459B | 78.10 |
| Verano Holdings (VRNO) | United States | $0.432B | 0.00 |
| Cerus (CERS) | United States | $0.413B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| Quanterix (QTRX) | United States | $0.279B | 0.00 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.240B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.212B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 18.45 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.195B | 57.33 |
| TerrAscend (TSNDF) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.74 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 24.96 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 31.08 |
| Cytosorbents (CTSO) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.40 |
| Jin Medical (ZJYL) | China | $0.025B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |